In the Mix: 8 More Articles — February 26, 2026

In the Mix
8 articles reviewed and scored below the CED clinical relevance threshold of 40. Organized by topic below. Some may still be relevant to your situation.
Jump to topic
CBD (3 articles)
#25 CBDSafetyResearch

Medterra CBD Review: Products, Testing Standards & Our Experience – Forbes

Medterra provides certificates of analysis for its CBD products, though ingredient information on product pages is limited. Third-party testing documentation is available on the company website to verify cannabinoid content and purity.

While Medterra makes certificates of analysis accessible to consumers, the sparse ingredient labeling on product pages may limit informed decision-making about formulation details.

Read more →
#20 CBDSafetyResearch

R&R CBD Review: Products, Testing Standards & Our Experience – Forbes

A Forbes review evaluates R&R CBD’s product line, which combines CBD with other cannabinoids in formulations both with and without THC to address various health needs. The assessment examines the company’s testing standards and overall product quality for consumers seeking multi-cannabinoid options.

R&R CBD’s multi-cannabinoid product formulations with varying THC content may offer broader therapeutic potential than isolated CBD alone, though efficacy depends on individual cannabinoid profiles and third-party verification standards.

Read more →
#18 CBDSafety

CBDistillery Review: Products, Testing Standards & Our Experience – Forbes

CBDistillery products undergo third-party laboratory testing to verify cannabinoid content and potency, with products containing measurable cannabinoids and terpene profiles. Testing standards ensure consumers receive accurate information about cannabinoid concentrations and additional plant compounds in each product.

Third-party verification of cannabinoid content and terpene profiles provides transparency regarding product composition and potency.

Read more →
Policy (5 articles)
#8 PolicySafety

Arizona senator proposes ‘public nuisance’ bill for marijuana smell – YouTube

An Arizona senator has proposed legislation to classify excessive marijuana smoke and odor as a public nuisance, citing potential harm to neighboring residents. The bill has received mixed reactions from stakeholders regarding the feasibility and implications of regulating cannabis-related odor in residential areas.

The proposal to regulate marijuana odor as a public nuisance raises questions about enforcement standards and the balance between cannabis users’ rights and community impacts in states with legal markets.

Read more →
#5 PolicyIndustry

The Des – In all, 24 states have passed legislation to legalize marijuana for recreational use …

Twenty-four states have now legalized marijuana for recreational use, with several states neighboring Iowa adopting similar legislation. The expansion of recreational cannabis availability across multiple states reflects shifting regulatory approaches to cannabis legalization across the United States.

The continued expansion of recreational marijuana legalization across state lines raises important questions about standardization of cannabis products, potency labeling, and clinical oversight in an increasingly fragmented regulatory landscape.

Read more →
#3 PolicyIndustry

Madison Township Zoning Commission OKs site plan for marijuana facility

A Madison Township Zoning Commission has approved a site plan for a marijuana cultivation facility in the area. The approval moves forward the development of the cannabis growing operation within the township’s jurisdiction.

Local zoning approval for cannabis cultivation facilities continues to expand infrastructure for legal marijuana production and distribution.

Read more →
#2 PolicySafetyIndustry

Union County officials seize drugs, candy-branded THC products in multi-agency operation

Law enforcement in Union County conducted a multi-agency operation targeting illegal THC retailers, resulting in the seizure of over $100,000 in products including candy-branded THC items. The operation focused on enforcing regulations against unauthorized drug sales at THC retail locations.

Multi-agency enforcement actions targeting unregulated THC retailers highlight ongoing challenges with product safety oversight and compliance in cannabis retail markets.

Read more →
#0 PolicyIndustry

Here’s Why Tenet Healthcare (THC) is a Strong Value Stock – Yahoo Finance

This article discusses Tenet Healthcare’s stock valuation metrics and investment potential based on financial analysis rather than cannabis-related clinical research. The piece is not relevant to cannabis medicine or cannabinoid science.

This article about Tenet Healthcare’s stock performance does not contain clinical or scientific information about cannabis or cannabinoids.

Read more →
📰 See the top-ranked articles at cedclinic.com/category/cannabis-news/